L. Scalise

Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma

L. Cascione, A. Stathis, E. Zucca, 2022, EJHaem.

Hydroxy-tyrosol as a Free Radical Scavenging Molecule in Polymeric Hydrogels Subjected to Gamma-Ray Irradiation

O. Sabry, M. Fiorini, P. Fattori, 2021 .

Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models.

L. Cascione, D. Rossi, A. Stathis, 2020, Blood advances.

Targeting CD25-positive lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as single agent or in combination with targeted agents

L. Cascione, A. Stathis, E. Zucca, 2023, bioRxiv.

Noninvasive prediction of axillary lymph node breast cancer metastasis using morphometric analysis of nodal tumor microvessels in a contrast-free ultrasound approach

Robert T. Fazzio, J. Carter, M. Fatemi, 2023, Breast Cancer Research.

Targeting CD19-positive lymphomas with the antibody-drug conjugate (ADC) loncastuximab tesirine: preclinical evidence as single agent and as combinatorial approach

L. Cascione, A. Stathis, E. Zucca, 2023, bioRxiv.